PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy

Programmed death protein 1 (PD1) is a common immunosuppressive member on the surface of T cells and plays an imperative part in downregulating the immune system and advancing self-tolerance. Its ligand programmed cell death ligand 1 (PDL1) is overexpressed on the surface of malignant tumor cells, wh...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Jinhua Liu, Zichao Chen, Yaqun Li, Wenjie Zhao, JiBiao Wu, Zhen Zhang
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2021-09-01
סדרה:	Frontiers in Pharmacology
נושאים:	PD-1 inhibitor PD-L1 inhibitor biomarkers immune checkpoint tumor immune escape immune-related toxicity
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fphar.2021.731798/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!